OvaScience (OVAS) Trading 0% Higher
OvaScience Inc (NASDAQ:OVAS)’s share price traded up 0% on Monday . The stock traded as high as $0.99 and last traded at $0.97. 1,489,900 shares were traded during mid-day trading, an increase of 74% from the average session volume of 856,083 shares. The stock had previously closed at $0.97.
Several equities analysts have weighed in on the stock. Zacks Investment Research lowered shares of OvaScience from a “buy” rating to a “hold” rating in a report on Wednesday, November 15th. HC Wainwright reiterated a “buy” rating and issued a $15.00 target price on shares of OvaScience in a report on Monday, November 6th.
Institutional investors have recently added to or reduced their stakes in the business. GMT Capital Corp acquired a new stake in OvaScience during the 3rd quarter worth approximately $1,138,000. Broadfin Capital LLC acquired a new stake in OvaScience during the 2nd quarter worth approximately $429,000. Sabby Management LLC lifted its holdings in OvaScience by 20.2% during the 2nd quarter. Sabby Management LLC now owns 509,300 shares of the biotechnology company’s stock worth $795,000 after buying an additional 85,525 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in OvaScience by 28.8% during the 2nd quarter. Wells Fargo & Company MN now owns 164,283 shares of the biotechnology company’s stock worth $256,000 after buying an additional 36,720 shares in the last quarter. Finally, Susquehanna International Group LLP lifted its holdings in OvaScience by 87.2% during the 2nd quarter. Susquehanna International Group LLP now owns 112,781 shares of the biotechnology company’s stock worth $176,000 after buying an additional 52,538 shares in the last quarter. Institutional investors own 54.88% of the company’s stock.
OvaScience, Inc is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company’s portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient’s own ovarian tissue.
Receive News & Ratings for OvaScience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OvaScience and related companies with MarketBeat.com's FREE daily email newsletter.